CD8A and neoplasm: TCF1+, but not TCF1– TILs proliferated more and gave rise to both TCF1+ and TCF1– CD8 T cells in response to PD-1 blockade, leading to significantly better and long-term control of tumor growth as compared to TCF1– TILs [71,77].